Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials.

Front Ophthalmol (Lausanne) · 2024 · PMC11575077 · PMID 39564145

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep=0.07so close (0.05 < p ≤ 0.1)

Improvements in the visual analog scale eye dryness score were significantly greater for perfluorohexyloctane versus saline in all patient subgroups evaluated, except for males, in which there was a numerical difference favoring perfluorohexyloctane that did not reach statistical significance (p=0.07; Figure 3B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.